(2019) Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines. Journal of Research in Pharmacy Practice. 228-+. ISSN 2319-9644
|
Text
10864.pdf Download (855kB) | Preview |
Abstract
Cutaneous leishmaniasis is caused by a flagellated parasite and transmitted through a bite by bloodsucking sand-flies.[1] Cutaneous leishmaniasis is characterized by ulcerative skin lesions. This is an endemic disease in the Middle East, especially Iran, Afghanistan, Pakistan, Bangladesh, Indian, and Nepal.[2] Since the 1940s, pentavalent antimony compounds have been considered as the first line of treatment for all forms of leishmaniasis. Meglumine antimoniate and sodium stibogluconate are the well-known pentavalent antimony agents.[3] Glucantime (Sanofi Aventis, France) is a brand product of meglumine antimoniate, which is supplied in 5 mL colorless ampules with concentration 300 mg/mL. Every five ampules are packed in a box, and there are not any visible particles in Glucantime ampules
Item Type: | Article |
---|---|
Keywords: | Pharmacology & Pharmacy |
Subjects: | QV Pharmacology > QV 701-835 Pharmacy and Pharmaceutics |
Divisions: | Faculty of Medicine > Departments of Clinical Sciences > Department of Skin Faculty of Pharmacy and Pharmaceutical Sciences > Student Research Committee Skin Diseases and Leishmaniasis Research Center |
Page Range: | 228-+ |
Journal or Publication Title: | Journal of Research in Pharmacy Practice |
Journal Index: | ISI |
Volume: | 8 |
Number: | 4 |
Identification Number: | https://doi.org/10.4103/jrpp.JRPP₁₉₈₄ |
ISSN: | 2319-9644 |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/10864 |
Actions (login required)
View Item |